Pfizer (PFE)
Pfizer Cash Flow
- Quarterly: March 2012 - December 2009 Previous Quarters
- Annual
| Cash Flow - Operations | 2012-03 | 2011-12 | 2011-09 | 2011-06 | 2011-03 | 2010-12 | 2010-09 | 2010-06 | 2010-03 | 2009-12 |
| Net Income | 1.803B | 1.45B | 3.749B | 2.618B | 2.234B | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro |
| Depreciation, Depletion, Amortization | 2.252B | 2.37B | 2.247B | 2.305B | 2.104B | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro |
| Other Non-Cash Items | 277.00M | -1.614B | -1.044B | 1.31B | -218.00M | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro |
| Total Non-Cash Items | 2.529B | 756.00M | 1.203B | 3.615B | 1.886B | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro |
| Deferred Income Taxes | -18.00M | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro | ||||
| Total Changes in Assets/Liabilities | -1.558B | 3.055B | -513.00M | -335.00M | 522.00M | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro |
| Other Operating Activities | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro | |||||
| Net Cash from Operating Activities | 2.774B | 5.261B | 4.439B | 5.898B | 4.642B | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro |
| Cash Flow - Investing | 2012-03 | 2011-12 | 2011-09 | 2011-06 | 2011-03 | 2010-12 | 2010-09 | 2010-06 | 2010-03 | 2009-12 |
| Capital Expenditures | -254.00M | -598.00M | -454.00M | -358.00M | -250.00M | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro |
| Acquisitions, Divestitures | -782.00M | -94.00M | 2.357B | 0.00 | -3.169B | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro |
| Investments | 1.516B | 1.588B | -2.10B | 517.00M | 4.14B | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro |
| Other Investing Activities | -29.00M | 3.00M | 412.00M | 202.00M | 4.00M | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro |
| Cash Flow - Financing | 2012-03 | 2011-12 | 2011-09 | 2011-06 | 2011-03 | 2010-12 | 2010-09 | 2010-06 | 2010-03 | 2009-12 |
| Net Cash from Investing Activities | 451.00M | 899.00M | 215.00M | 361.00M | 725.00M | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro |
| Debt Issued | -233.00M | -1.599B | -394.00M | -132.00M | -3.416B | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro |
| Equity Issued | -1.659B | -3.211B | -2.11B | -2.249B | -1.43B | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro |
| Dividends Paid | -1.65B | -1.524B | -1.551B | -1.568B | -1.591B | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro |
| Other Financing Activities | 35.00M | 84.00M | 20.00M | 31.00M | 33.00M | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro |
| Net Cash from Financing Activities | -3.507B | -6.25B | -4.035B | -3.918B | -6.404B | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro |
| Foreign Exchange Effects | 34.00M | -77.00M | -9.00M | 25.00M | 32.00M | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro |
| Net Change in Cash & Cash Equivalents | -248.00M | -167.00M | 610.00M | 2.366B | -1.005B | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro |
| Cash at beginning of period | 3.182B | 1.735B | 3.539B | 3.706B | 3.096B | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro |
| Cash at end of period | 2.934B | 3.539B | 3.706B | 3.096B | 730.00M | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro |
